• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斑马鱼作为罕见遗传性神经肌肉疾病研究的模式生物。

Zebrafish as a Model Organism for Research in Rare Genetic Neuromuscular Diseases.

作者信息

Akyürek Eylem Emek, Erba Martina, Dalla Barba Francesco, Sandonà Dorianna, Sacchetto Roberta

机构信息

Department of Comparative Biomedicine and Food Science, University of Padova, Viale dell'Università 16, Legnaro, 35020 Padova, Italy.

Department of Biomedical Sciences, University of Padova, 35131 Padova, Italy.

出版信息

Int J Mol Sci. 2025 Sep 10;26(18):8832. doi: 10.3390/ijms26188832.

DOI:10.3390/ijms26188832
PMID:41009401
Abstract

The zebrafish () has become one of the most popular and valuable model organisms for studying rare neuromuscular diseases. Its unique characteristics, including the high number of offspring produced with each mating, transparent eggs, rapid development, and genetic similarity to humans, make this small vertebrate ideal for investigating complex and rare disorders affecting the skeletal muscle, such as Duchenne Muscular Dystrophy (DMD), Limb Girdle Muscular Dystrophies (LGMDs), and Brody Myopathy (BM). Various zebrafish models, both natural mutants and genetically engineered strains, have been developed to study these conditions. These models enable the deciphering of pathogenetic mechanisms, the real-time monitoring of disease progression, high-throughput drug screening, and the testing of novel therapeutic approaches. As research progresses, zebrafish models are likely to play an increasingly crucial role in unravelling the complexities of rare neuromuscular diseases and developing targeted therapies, offering hope for affected patients.

摘要

斑马鱼已成为研究罕见神经肌肉疾病最受欢迎且最具价值的模式生物之一。它具有独特的特征,包括每次交配产生的后代数量众多、卵透明、发育迅速以及与人类的基因相似性,这使得这种小型脊椎动物成为研究影响骨骼肌的复杂罕见疾病(如杜氏肌营养不良症(DMD)、肢带型肌营养不良症(LGMDs)和布罗迪肌病(BM))的理想选择。已经开发了各种斑马鱼模型,包括自然突变体和基因工程菌株,用于研究这些病症。这些模型有助于解读发病机制、实时监测疾病进展、进行高通量药物筛选以及测试新型治疗方法。随着研究的进展,斑马鱼模型在揭示罕见神经肌肉疾病的复杂性和开发靶向治疗方面可能会发挥越来越关键的作用,为受影响的患者带来希望。

相似文献

1
Zebrafish as a Model Organism for Research in Rare Genetic Neuromuscular Diseases.斑马鱼作为罕见遗传性神经肌肉疾病研究的模式生物。
Int J Mol Sci. 2025 Sep 10;26(18):8832. doi: 10.3390/ijms26188832.
2
An Overview of Recent Advances and Clinical Applications of Exon Skipping and Splice Modulation for Muscular Dystrophy and Various Genetic Diseases.外显子跳跃和剪接调控在肌肉萎缩症及多种遗传疾病中的最新进展与临床应用概述
Methods Mol Biol. 2025;2964:53-83. doi: 10.1007/978-1-0716-4730-1_3.
3
Muscular Dystrophies.肌肉萎缩症
Adv Exp Med Biol. 2025;1478:245-284. doi: 10.1007/978-3-031-88361-3_11.
4
Vesicoureteral Reflux膀胱输尿管反流
5
Identifying kinematic biomarkers of the dystrophic phenotype in a zebrafish model of Duchenne muscular dystrophy.在杜兴氏肌营养不良症的斑马鱼模型中鉴定营养不良表型的运动生物标志物。
Skelet Muscle. 2025 Jun 20;15(1):17. doi: 10.1186/s13395-025-00382-6.
6
Dystrophinopathies肌营养不良症
7
Genetic and Clinical Spectrum of Limb-Girdle Muscular Dystrophies in Western Sicily.西西里岛西部地区肢带型肌营养不良症的遗传和临床谱系
Genes (Basel). 2025 Aug 21;16(8):987. doi: 10.3390/genes16080987.
8
Salzmanns Nodular Corneal Degeneration萨尔茨曼结节状角膜变性
9
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
10
MicroRNAs as a Tool for Differential Diagnosis of Neuromuscular Disorders.微小 RNA 作为神经肌肉疾病鉴别诊断的工具。
Neuromolecular Med. 2023 Dec;25(4):603-615. doi: 10.1007/s12017-023-08763-0. Epub 2023 Oct 19.

本文引用的文献

1
Calpainopathy (limb-girdle muscular dystrophy type R1): clinical features, diagnostic approaches, and biotechnological treatment methods.钙蛋白酶病(1型R型肢带型肌营养不良症):临床特征、诊断方法及生物技术治疗手段
J Neuromuscul Dis. 2025 Sep;12(5):594-618. doi: 10.1177/22143602251345967. Epub 2025 Jun 2.
2
The effects of glucocorticoids on cardiac function of patients with Duchenne muscular dystrophy: benefit or not?糖皮质激素对杜氏肌营养不良症患者心脏功能的影响:有益还是无益?
Eur J Pediatr. 2025 Apr 26;184(5):313. doi: 10.1007/s00431-025-06141-5.
3
Treatabolome for finely targeting muscle pathology in LGMD.
用于精准靶向肢带型肌营养不良症肌肉病理的治疗代谢组
Acta Myol. 2025 Mar;44(1):37-41. doi: 10.36185/2532-1900-1035.
4
JAG1 overexpression partially rescues muscle function in a zebrafish model of duchenne muscular dystrophy.JAG1基因过表达可部分挽救杜兴氏肌营养不良斑马鱼模型的肌肉功能。
J Genet. 2025;104.
5
The novel use of the CFTR corrector C17 in muscular dystrophy: pharmacological profile and in vivo efficacy.CFTR校正剂C17在肌营养不良症中的新用途:药理学特征及体内疗效
Biochem Pharmacol. 2025 Mar;233:116779. doi: 10.1016/j.bcp.2025.116779. Epub 2025 Jan 24.
6
The Zebrafish Mutant in the Assessment of a Novel Pharmaceutical Approach to Brody Myopathy.斑马鱼突变体在评估布罗迪肌营养不良症新型药物治疗方法中的应用。
Int J Mol Sci. 2024 Aug 25;25(17):9229. doi: 10.3390/ijms25179229.
7
Advanced therapeutic approaches in sarcoglycanopathies.肌聚糖病的先进治疗方法。
Curr Opin Pharmacol. 2024 Jun;76:102459. doi: 10.1016/j.coph.2024.102459. Epub 2024 May 6.
8
The Dysferlinopathies Conundrum: Clinical Spectra, Disease Mechanism and Genetic Approaches for Treatments.肌营养不良蛋白病的难题:临床谱、疾病机制和治疗的遗传方法。
Biomolecules. 2024 Feb 21;14(3):256. doi: 10.3390/biom14030256.
9
Standardization of zebrafish drug testing parameters for muscle diseases.斑马鱼肌肉疾病药物测试参数的标准化。
Dis Model Mech. 2024 Jan 1;17(1). doi: 10.1242/dmm.050339. Epub 2024 Jan 18.
10
Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E/R4: phase 1/2 trial results.用 bidridistrogene xeboparvovec 进行基因治疗治疗肢带型肌营养不良症 2E/R4:1/2 期临床试验结果。
Nat Med. 2024 Jan;30(1):199-206. doi: 10.1038/s41591-023-02730-9. Epub 2024 Jan 4.